整合影像组学与剂量组学及肺生物等效剂量预测肺癌SBRT后症状性放射性肺炎:双中心研究
本研究基于肺生物等效剂量分割方法,开发并验证整合影像组学和剂量组学特征的综合模型,用于预测肺癌立体定向体部放疗(SBRT)后症状性放射性肺炎(SRP)。双中心182例SBRT肺癌患者分为训练集、验证集和外部测试集,提取全肺及BED区域的影像组学和剂量组学特征。肺VBED70(α/β=3 Gy)是SRP独立危险因素,基于BED的模型优于全肺模型,R+D+DVH三联模型预测准确性最高(AUC 0.889,95%CI 0.701-0.956),校准稳健且临床实用。
要点
- 肺VBED70(α/β=3 Gy)是SBRT后SRP的独立危险因素。
- 基于BED区域的影像组学和剂量组学模型优于全肺模型。
- R+D+DVH三联模型预测SRP的AUC达0.889,校准和临床效用良好。
核心结论
- 基于肺生物等效剂量分割方法的R+D+DVH三联模型在预测不同SBRT分割方案下的SRP方面优于其他模型。
研究设计与样本
- 双中心回顾性队列研究,纳入182例接受SBRT的肺癌患者,分为训练集、验证集和外部测试集。
- 从计划CT图像和3D剂量分布图中提取全肺及BED区域的影像组学和剂量组学特征,采用相关滤波和LASSO正则化进行特征选择。
- 使用五种机器学习算法构建三个单一模型(DVH、影像组学R、剂量组学D)和三个联合模型(R+DVH、R+D、R+D+DVH),通过ROC分析、校准和决策曲线分析评估性能。
主要发现
- 肺VBED70(α/β=3 Gy)被认定为SRP的独立危险因素。
- 基于BED的影像组学模型AUC为0.806,优于全肺模型的0.674;基于BED的剂量组学模型AUC为0.821,优于全肺模型的0.647。
- R+D+DVH三联模型预测准确性最高,AUC为0.889(95%CI 0.701-0.956),校准稳健且临床实用。
临床怎么用
- 可基于计划CT和剂量分布提取BED区域的影像组学和剂量组学特征,结合DVH参数构建R+D+DVH模型预测SRP风险。
- 肺VBED70(α/β=3 Gy)可作为SRP的独立危险因素用于风险分层。
局限性
- 原文未报告局限性内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: This study focused on developing and validating a composite model that integrates radiomic and dosiomic features based on a lung biologically equivalent dose segmentation approach to predict symptomatic radiation pneumonitis (SRP) following lung SBRT. MATERIALS AND METHODS: A dual-centered cohorts of 182 lung cancer patients treated with SBRT were divided into training, validation, and external testing sets. Radiomic and dosiomic features were extracted from two distinct regions of interest (ROIs) in the planning computed tomography (CT) images and 3D dose distribution maps, which encompassed both the entire lung and biologically equivalent dose (BED) regions. Feature selection involved correlation filters and LASSO regularization. Five machine learning algorithms generated three individual models (dose-volume histogram [DVH], radiomic [R], dosiomic [D]) and three combined models (R + DVH, R + D, R + D + DVH). Performance was evaluated via ROC analysis, calibration, and decision curve analysis. RESULTS: Among the clinical and dosimetric factors, VBED70 (α/β = 3 Gy) of the lung was recognized as an independent risk factor for SRP. BED-based radiomic and dosiomic models outperformed whole-lung models (AUCs: 0.806 vs. 0.674 and 0.821 vs. 0.647, respectively). The R + D + DVH trio model achieved the highest predictive accuracy (AUC: 0.889, 95 % CI: 0.701-0.956), with robust calibration and clinical utility. CONCLUSIONS: The R + D + DVH trio model based on lung biologically equivalent dose segmentation approach outperforms other models in predicting SRP across various SBRT fractionation schemes.
引用
- Jiao Y, Wen Y, Li S, et al. Integrating radiomics and dosiomics with lung biologically equivalent dose for predicting symptomatic radiation pneumonitis after lung SBRT: A dual-center study. Radiother Oncol. 2025. PMID: 40939682. doi:10.1016/j.radonc.2025.111129
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。